TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-135.81M
↓ 83% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-74.26M
Historical baseline
PeriodValueYoY Change
TTM$-135.81M-0.7%
2024$-134.82M-44.3%
2023$-93.46M-40.3%
2022$-66.64M-37.0%
2021$-48.64M-85.4%
2020$-26.23M-84.6%
2019$-14.21M-